Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Granules IndiaBOM:532482 -0.48%81 Operating Margin % is 17.70% as of Jun. 2026, which is 8% above its 10-year median of 16.39. GuruFocus rates BOM:532482 with a GF Score™ of 81/100 and a GF Value™ of ₹637.97 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 960 Drug Manufacturers companies, Granules India ranks better than 76.67% on this metric.
Granules India Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -3.8%.
The historical rank and industry rank for Granules India's Operating Margin % or its related term are showing as below:
BOM:532482'
s Operating Margin % Range Over the Past 10 Years
Min: 12.44 Med: 16.39 Max: 22.39
Current: 17.34
BOM:532482's Operating Margin % is ranked better than 76.67% of 960
companies
in the Drug Manufacturers industry
Industry Median: 7.595
vs BOM:532482: 17.34
Granules India's 5-Year Average Operating Margin % Growth Rate was -3.80% per year.
Granules India (BOM:532482) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Granules India Operating Margin % Related Terms
Granules India Operating Margin % Historical Data
* Premium members only.
The historical data trend for Granules India's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Granules India Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Granules India's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Granules India's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Granules India's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Granules India (BOM:532482) has a Operating Margin % of 17.70% as of Jun. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Granules India and its competitors. This is near median its historical median of 16.39. Over the past decade, Granules India's Operating Margin % has ranged from 12.44 to 22.39. According to the industry distribution chart, Granules India ranks #224 out of 960 companies in the Drug Manufacturers industry, placing it in the top 23.3%.
Is Granules India's Operating Margin % too high?
Granules India's current Operating Margin % of 17.70% is near median its 10-year median of 16.39. Over the past 10 years, this metric has ranged from a low of 12.44 to a high of 22.39. The Drug Manufacturers industry median Operating Margin % is 7.60. Granules India's value of 17.70% is 133% above this industry median. Based on the distribution chart, Granules India ranks #224 out of 960 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Granules India has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Granules India's Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Granules India ranks #224 out of 960 companies for Operating Margin %. This places Granules India in the top 23% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 7.60. Granules India's value of 17.70% is 133% above this benchmark. Historically, Granules India's own Operating Margin % has ranged from 12.44 to 22.39 over the past decade. While the company's 10-year median is 16.39 vs. the industry median of 7.60, Granules India has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.60, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Granules India's current Operating Margin % of 17.70% is 133% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Granules India and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Granules India's current Operating Margin % is 17.70%, which is near median its own 10-year median of 16.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Granules India stock overvalued right now?
Based on GuruFocus' analysis, Granules India (BOM:532482) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹637.97, compared to a current price of ₹841.65 — trading 31.9% above its estimated fair value. The current Operating Margin % is 17.70%, which is near median its 10-year median of 16.39 and 133% above the Drug Manufacturers industry median of 7.60. Granules India's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Granules India (BOM:532482), the current Operating Margin % is 17.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Granules India (BOM:532482) Overvalued in 2026?
Based on GuruFocus' analysis, Granules India stock appears to be overvalued.
The current stock price of ₹841.65 is trading 31.9% above its estimated GF Value™ of ₹637.97.
GuruFocus considers Granules India to be Significantly Overvalued.
Key valuation signals for BOM:532482:
Operating Margin %: 17.70% (near median its 10-year median of 16.39)
GF Value™: ₹637.97 vs. price of ₹841.65 (31.9% above fair value)
Industry Position: 133% above the Drug Manufacturers median (#224 of 960)
No single metric tells the full story. See the BOM:532482 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and the Rest of the World. The company generates a majority of its revenue from its business outside India.
81GF Score
Get the complete analysis for BOM:532482
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532482 has been successfully added to your 
